Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $241.000 thousand which missed the analyst consensus estimate of $340.000 thousand by 29.12 percent.